mitochondrial peptide ss 31 is a small peptide that accumulates in mitochondria

Isabella Young logo
Isabella Young

mitochondrial peptide ss 31 SS - SS-31peptidebenefits Szeto-Schiller (SS) peptides Exploring the Potential of Mitochondrial Peptide SS-31: A Deep Dive into Its Applications and Benefits

SS-31 Reddit The field of therapeutic peptides is rapidly evolving, with mitochondrial peptide SS-31 emerging as a significant area of research作者:Q WANG·2024—SS-31, also known as Bendavia, is a novelpeptidecompound designed to target the innermitochondrialmembrane.. This mitochondria-targeting antioxidant has garnered considerable attention for its potential to address a range of cellular dysfunctions and age-related conditions. As a synthetic peptide that improves mitochondrial function, SS-31 represents a promising avenue for therapeutic interventionMitochondrial protein interaction landscape of SS-31 - PNAS. This article will delve into the scientific underpinnings of mitochondrial peptide SS-31, exploring its mechanism of action, demonstrated benefits, and ongoing research.

Understanding the Mechanism of Action: Targeting the Powerhouses of the Cell

Mitochondria, often referred to as the "powerhouses of the cell," are critical for energy production and cellular health作者:W Mitchell·2020·被引用次数:124—The mitochondria-targeted peptide SS-31binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action.. Mitochondrial dysfunction is implicated in numerous diseases and the aging process.Mitochondrial protein interaction landscape of SS-31 - PNAS SS-31, also known by its developmental names Elamipretide and Bendavia, is specifically designed to target mitochondria. Its unique structure allows it to accumulate within these organelles, particularly at the inner mitochondrial membrane.

One of the key mechanisms by which SS-31 exerts its effects is through its potent antioxidant properties. It has demonstrated remarkable efficacy in reducing elevated levels of reactive oxygen species (ROS), which are harmful byproducts of cellular metabolism that can damage cellular components.SS-31, MOTS-c help with Mitochondrial function and aging By decreasing mitochondrial reactive oxygen species production, SS-31 helps to protect cells from oxidative stress. Furthermore, SS-31 binds with high affinity to cardiolipin, a phospholipid uniquely found in the inner mitochondrial membrane, playing a crucial role in maintaining mitochondrial structure and function. This interaction is a key component of its mechanism of actionMitochondria‐Targeted Peptide SS31 Attenuates Renal ....

Research has shown that SS-31 can prevent mitochondrial depolarization, a critical event that compromises energy production. It also helps to restore mitochondrial morphology, a key indicator of cellular health.The mitochondrial-targeted peptide, SS-31, improves ... Studies have indicated that SS-31 can upregulate frataxin expression, a protein essential for mitochondrial iron metabolism and heme synthesis, thereby improving the overall quality of mitochondria. This makes it a significant therapeutic candidate for conditions associated with mitochondrial disorders.作者:DF Dai·2011·被引用次数:430—Mitochondrial targeted peptide SS-31ameliorates cardiomyopathy resulting from prolonged Ang stimulation as well as Gαq overexpression, suggesting its potential ...

Demonstrated Benefits Across Various Health Domains

The therapeutic potential of mitochondrial peptide SS-31 has been explored in a variety of preclinical and clinical settings, revealing a broad spectrum of benefits:

Cardiovascular Health

SS-31 treatment has shown promise in ameliorating cardiac conditions. It has been found to provide a beneficial effect on macrophages from foam cell formation, likely through both ROS scavenging and inhibition of cholesterol influx. Furthermore, Mitochondrial targeted peptide SS-31 has been shown to ameliorate cardiomyopathy resulting from prolonged Angiotensin II stimulation as well as Gαq overexpression.作者:S Hao·2015·被引用次数:53—SS-31provides a beneficial effect on macrophages from foam cell formation, likely, through both ROS scavenging and inhibition of cholesterol influx. In models of heart failure, SS-31 is currently undergoing clinical trials, highlighting its advancing therapeutic status.

Renal Health

In the context of kidney health, SS-31 has demonstrated protective effects. SS31 protected renal tubulointerstitial injury in diabetic mice through a decrease in mitochondrial fragmentation. It has also been observed that SS-31 treatment improved age-related mitochondrial morphology and glomerulosclerosis. Assessment of glomeruli revealed that SS-31 reduced senescence markers, such as p16, suggesting a role in mitigating age-related kidney declineTherapeutic Peptide SS-31 Modulates Membrane Binding ....

Neurological Function and Neuroprotection

The ability of SS-31 to cross the blood-brain barrier and target the inner mitochondrial membrane (IMM) makes it a compelling candidate for neurological applications. SS-31 improves cognitive functions by promoting mitochondrial and synaptic health and decreasing neuroinflammation. In models of cognitive impairment, SS-31 has shown neuroprotective benefits. Furthermore, SS-31 emerges as a promising therapeutic candidate to attenuate neurodegeneration pertinent to α-synuclein misfolding and aggregation, a hallmark of diseases like Parkinson'sThe mitochondria-targeted peptide SS-31 binds lipid bilayers .... Treatment with the Mitochondrial-Targeted Antioxidant Peptide SS-31 has also been shown to rescue neurovascular coupling responses and support cerebrovascular endothelial health.

Other Therapeutic Applications

The broad impact of SS-31 on mitochondrial function extends to other areasTHE MITOCHONDRIAL TARGETING PEPTIDE SS-31 .... It has been investigated for its role in conditions such as Friedreich's ataxia, where it upregulates frataxin expression and improves the quality of mitochondria.SS-31 Peptide: A Breakthrough in Regenerative Medicine ... Its antioxidant properties also contribute to its beneficial effects in conditions associated with oxidative stress.

The Future of SS-31: Research and Development

The growing body of scientific literature underscores the significant potential of mitochondrial peptide SS-31. It is recognized as a breakthrough mitochondrial peptide with powerful potential for cellular energy, repair, and longevity.The SS-31 peptide is revolutionizing regenerative medicine byimproving mitochondrial function, increasing ATP production, and enhancing overall cellular ... The Szeto-Schiller (SS) peptides, a class to which SS-31 belongs, are amphipathic tetrapeptides that are efficacious toward a wide array of mitochondrial disorders.

As research progresses, understanding the optimal SS-31 peptide dosage and SS-31 protocol will be crucial for its clinical application. While the journey from preclinical research to widespread therapeutic use involves rigorous testing and regulatory approval, the current findings surrounding SS-31 are highly encouraging.Mitochondrial protein interaction landscape of SS-31 - PNAS Its ability to directly address fundamental cellular energetic dysfunction positions it as a key player in the future of regenerative medicine and the treatment of age-related diseases. The ongoing exploration into its interactions with mitochondrial proteins and its broad therapeutic applications continues to solidify its importance in the scientific community.

Log In

Sign Up
Reset Password
Subscribe to Newsletter

Join the newsletter to receive news, updates, new products and freebies in your inbox.